DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Ashok Leyland, NMDC, Voltas and 7 Other Top Stocks Announcing Q1 Results Today

Trade Brains 3 hrs ago·14 Aug 2026, 2:30 am

Alkem Laboratories is set to release its first-quarter results for FY27 today. This financial update will reveal the company's performance over the last three months, including its revenue, profit, and operational efficiency.

For investors, this report is a key indicator of the company's current health and growth trajectory. It helps gauge how well the company is navigating the competitive landscape and managing its costs. Positive results could signal strong demand for its products, while a miss might raise concerns about market challenges.

Investors should watch for updates on sales growth, margins, and any guidance provided by management for the upcoming quarters. This information will be crucial in determining the stock's short-term performance and long-term investment potential.